19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) | API | CEP/COS | Details of Certificates of Suitability | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha)
CEP/COS

PharmaCompass Sponsored Ads

Contact Supplier

Gonane Norethisterone acetate

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha)

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 12 USDMF, 4 CEP/COS, 2 JDMF, 3 EU WC, 6 NDC API, 10 Listed Suppliers, $ API Reference Price

21 API Suppliers
12 USDMF
4 CEP/COS
2 JDMF
3 EU WC
6 NDC API
10 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

FINISHED DOSAGE FORMULATIONS

172 FDF Dossiers, 119 FDA Orange Book, 39 Europe, 7 Canada, 7 Listed Dossiers

172 FDF Dossiers
119 FDA Orange Book
39 Europe
7 Canada
7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.02MG;1MG, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 11.25MG/VIAL,N/A;N/A,5MG, INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 3.75MG/VIAL,N/A;N/A,5MG, CAPSULE;ORAL - 0.02MG;1MG, TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR, TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG;0.5MG, TABLET;ORAL - 0.0025MG;0.5MG, TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A

TABLET;ORAL-28 - 0.02MG;1MG
TABLET;ORAL-21 - 0.03MG;1.5MG
TABLET;ORAL-21 - 0.03MG;1.5MG
TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 11.25MG/VIAL,N/A;N/A,5MG
INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 3.75MG/VIAL,N/A;N/A,5MG
CAPSULE;ORAL - 0.02MG;1MG
TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR
TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 1MG;0.5MG
TABLET;ORAL - 0.0025MG;0.5MG
TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 5 SPI Pharma, 4 DKSH, 7 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 4 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 19 BASF, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 11 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 38 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

84 Fillers, Diluents & Binders, 56 Coating Systems & Additives, 40 Direct Compression, 33 Disintegrants & Superdisintegrants, 29 Controlled & Modified Release, 27 Granulation, 25 Solubilizers, 23 Thickeners and Stabilizers, 21 Lubricants & Glidants, 19 Co-Processed Excipients, 17 Taste Masking, 16 Film Formers & Plasticizers, 14 Parenteral, 10 Emulsifying Agents, 9 Topical, 8 API Stability Enhancers, 7 Chewable & Orodispersible Aids, 6 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

84 Fillers, Diluents & Binders
56 Coating Systems & Additives
40 Direct Compression
33 Disintegrants & Superdisintegrants
29 Controlled & Modified Release
27 Granulation
25 Solubilizers
23 Thickeners and Stabilizers
21 Lubricants & Glidants
19 Co-Processed Excipients
17 Taste Masking
16 Film Formers & Plasticizers
14 Parenteral
10 Emulsifying Agents
9 Topical
8 API Stability Enhancers
7 Chewable & Orodispersible Aids
6 Rheology Modifiers
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 47 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
47 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 40 Finished Drug Prices, 9 Annual Reports

2 US Medicaid Prescriptions
40 Finished Drug Prices
9 Annual Reports

MARKET PLACE

7 APIs

7 APIs

PATENTS & EXCLUSIVITIES

9 US Patents, 5 US Exclusivities

9 US Patents
5 US Exclusivities

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 3 Others

2 EDQM
1 USP
3 Others

$ API Ref.Price (USD/KG) : 7,469 Xls

Filters

Reset all filters

Filters

FILTER :

filter Certificate Holder Reset all filters

4 All

01 1ASPEN OSS B.V. Oss NL

02 1BAYER AG Leverkusen DE

03 1GEDEON RICHTER PLC Budapest HU

04 1VALDEPHARM Val de Reuil FR

filter Substance Reset all filters

4 All

01 3Norethisterone acetate

02 1Norethisterone acetate, micronised, non-micronised

filter Country Reset all filters

4 All

01 1France

02 1Germany

03 1Hungary

04 1Netherlands

filter Status Reset all filters

4 All

01 4Valid

Coral Drugs Norethisterone Acetate

List of Suppliers

Product Main Page

ASPEN OSS B.V. Oss NL

Contact Supplier

Aspen API. More than just an API.

Contact Supplier

Contact Supplier

Digital Content

Norethisterone acetate

Product Web Link

Digital Content

Certificate Number

R1-CEP 1996-042 - Rev 07

Status

Valid

Type

Chemical

Issue Date

2022-11-25

End Date

Substance Number

850

Aspen API Comapny Banner

01

ASPEN OSS B.V. Oss NL

Aspen API. More than just an API.

Contact Supplier

Contact Supplier

Digital Content

Norethisterone Acetate

Certificate Number : R1-CEP 1996-042 - Rev 07

Status : Valid

Issue Date : 2022-11-25

Type : Chemical

Substance Number : 850

Aspen API Comapny Banner

Product Web Link

Digital Content

BAYER AG Leverkusen DE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Norethisterone acetate

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Certificate Number

R1-CEP 2000-111 - Rev 04

Status

Valid

Type

Chemical

Issue Date

2017-06-22

End Date

Substance Number

850

02

BAYER AG Leverkusen DE

Pharma, Lab & Chemical Expo

Not Confirmed

BAYER AG Leverkusen DE

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Norethisterone Acetate

Certificate Number : R1-CEP 2000-111 - Rev 04

Status : Valid

Issue Date : 2017-06-22

Type : Chemical

Substance Number : 850

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

VALDEPHARM Val de Reuil FR

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Norethisterone acetate, micronised, non-micronised

Product Web Link

Digital Content

Certificate Number

R1-CEP 2011-242 - Rev 02

Status

Valid

Type

Chemical

Issue Date

2023-04-03

End Date

Substance Number

850

03

VALDEPHARM Val de Reuil FR

Pharma, Lab & Chemical Expo

Not Confirmed

VALDEPHARM Val de Reuil FR

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Norethisterone Acetate, Micronised, Non-micronis...

Certificate Number : R1-CEP 2011-242 - Rev 02

Status : Valid

Issue Date : 2023-04-03

Type : Chemical

Substance Number : 850

Product Web Link

Digital Content

GEDEON RICHTER PLC Budapest HU

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Norethisterone acetate

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Certificate Number

CEP 2021-402 - Rev 01

Status

Valid

Type

Chemical

Issue Date

2024-11-25

End Date

Substance Number

850

04

GEDEON RICHTER PLC Budapest HU

Pharma, Lab & Chemical Expo

Not Confirmed

GEDEON RICHTER PLC Budapest HU

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Norethisterone Acetate

Certificate Number : CEP 2021-402 - Rev 01

Status : Valid

Issue Date : 2024-11-25

Type : Chemical

Substance Number : 850

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) Manufacturers | Traders | Suppliers

19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) Manufacturers, Traders, Suppliers 1

20

We have 4 companies offering 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha)

Get in contact with the supplier of your choice:

Aspen API
Bayer AG
Fareva
Gedeon Richter

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?